Discordance between Self-reported and Biologically Tested Exposure to Fentanyl among People at Risk of Opioid Overdose

Ju Nyeong Park, Glenna Urquhart, Miles Morris, Rejwi Dahal, Saba Rouhani, Susan G. Sherman

Research output: Contribution to journalArticlepeer-review

Abstract

Drug overdose remains a leading cause of death in the US, and the majority of opioid overdose fatalities involve fentanyl. This study aims to measure the degree of concordance between self-reported and biologically tested exposure to fentanyl. We conducted a cross-sectional analysis using survey and urinalysis data collected between 2019 and 2020 from Anne Arundel County, Maryland. Among urinalysis participants (n =113), 30% reported daily fentanyl use, and among this group, only 54% had a fentanyl-positive result. Cohen Kappa between self-reported and biologically detected fentanyl use was 0.26, indicating minimal agreement between the 2 markers. Limitations to interpreting self-reported and urinalysis data are discussed in this report.

Original languageEnglish (US)
Pages (from-to)722-724
Number of pages3
JournalJournal of Addiction Medicine
Volume16
Issue number6
DOIs
StatePublished - Nov 1 2022

Keywords

  • drug testing
  • overdose
  • substance use

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Discordance between Self-reported and Biologically Tested Exposure to Fentanyl among People at Risk of Opioid Overdose'. Together they form a unique fingerprint.

Cite this